Thursday, July 18, 2019
wellness India Expo
Home Tags CDSCO

Tag: CDSCO

DCGI’s proposal for introducing unique code to drug packs gets nod...

The Drug Controller General India (DCGI) has proposed to introduce a unique code on drug packs whether it is a bottle, strip or vial to ensure the authenticity of the medicine.............

International Clinical Trials Day Special: Can Indian clinical research industry regain...

There was a time when India was set to be the biggest market for CRO business but then few incidents, bad press and tight regulations made it almost irrelevant. However, looks like there is still a hope for the industry. An analysis............

“Clinical research environment is improving at a decent pace”

Mentioned Dr Renu Razdan, Senior Vice President, JSS Research in her exclusive interaction with the BioVoice News, where she expressed her views on the clinical research scenario in India besides sharing few updates on her company's latest operations.................

No need to fear the regulator: DCGI

Calling upon the industry members to approach the Central Drugs Standard Control Organization (CDSCO) for any complaint or resolving of issues, the Drug Controller General of India, Dr S Eswara Reddy has informed that a special cell has been created to take care of it..............

CSDCO waives off NOC for export of Indian healthcare products

The Drug Controller General of India in his latest order has waived off the requirement of no objection certificate for export of medical device consignments to all countries...............

India and Japan to intensify cooperation in medical device regulations

While the move is expected to facilitate capacity building for increased competitiveness from imports. Indian medical device industry has also invited Japanese investors for ‘Make in India’ program.........

BioVoice eMag April 2017 Issue-11 Volume-1

BioVoice eMag April 2017 Issue-11 Volume-1: The ‘April 2017’ issue of BioVoice eMagazine includes the COVER STORY on Biorevolution 2.0: India’s quest to become a biotech...

CDSCO approves first autologous dendritic cell-based immuno-oncology product

APAC Biotech was granted with a commercial license by CDSCO to market its product, APCEDEN, a dendritic cell-based autologous immuno-oncology product for four cancer indications....

Experts discuss status of homeopathy regulations globally

The first-of-its-kind forum at Delhi addresses various regulatory issues considering the increased perception of the international world towards India as a key player in the progress of the homoeopathy drug industry....

Towards cashless bioeconomy: A rhetoric or real possibility?

Besides boosting the economic health of country, the demonetization of currency notes is also expected to have wider implications on the bioscience industry policies.....